Product Information
LORAZEPAM 0.5 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.0334 per EA under NDC 13107008301. Its NADAC has been published 263 times since Aug 11, 2021.
FDA first approved this application on Dec 22, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107008301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA203572FDA Approved
12/22/2017
TE Code
AB
On Market Since
2/1/2021
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 0.5 MG TABLET has been published 263 times since Aug 11, 2021, and over the history we have for it it has declined 24.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0334 per EA |
|---|---|
| All-time high | $0.0464 (Mar 13, 2024) |
| All-time low | $0.0315 (Nov 20, 2024) |
| 52-week high | $0.0430 |
| 52-week low | $0.0328 |
| Median price | $0.0401 |
| Average price | $0.0397 |
| Largest weekly change | +28.1% (Aug 21, 2024) |
| Weeks tracked | 263 |
| Tracking since | Aug 11, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 0.5 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.0334 per EA (NDC 13107008301), effective Aug 19, 2026.
How has the price of LORAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 0.5 MG TABLET has declined 24.8%. It has been tracked across 263 weekly CMS publications since Aug 11, 2021.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 0.5 MG TABLET?
Since Aug 11, 2021, the NADAC for LORAZEPAM 0.5 MG TABLET has ranged from a low of $0.0315 (Nov 20, 2024) to a high of $0.0464 (Mar 13, 2024), with a median of $0.0401 per EA.
Are there cheaper alternatives to LORAZEPAM 0.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LORAZEPAM 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LORAZEPAM 0.5 MG TABLET?
LORAZEPAM 0.5 MG TABLET (NDC 13107008301) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.